Sensyne Health Ltd. is a healthcare technology company, which engages in the discovery and development of new medicines. It also develops clinically validated software applications by artificial intelligence consisting of prescribed digital therapeutics and hospital systems. Its products include SEND, GDm-Health, CVm-Health, DBm-Health, CleanSpace, and EDGE. The company was founded on June 20, 2018 and is headquartered in Oxford, the United Kingdom.
OTC